Stool DNA Integrity Method for Colorectal Cancer Detection

  • Claudia Rengucci
  • Giulia De Maio
  • Maura Menghi
  • Daniele Calistri
Protocol
Part of the Methods in Molecular Biology book series (MIMB, volume 1765)

Abstract

Fluorescence long DNA (FL-DNA) is a non-invasive and simple-to-perform stool DNA test. This assay consists of a qualitative and quantitative real-time PCR (RT PCR) analysis. FL-DNA has great potential in colorectal cancer (CRC) lesions detection used alone or in combination with the standard CRC screening tool: immunochemical fecal occult blood test (iFOBT).

Key words

FL-DNA CRC Stool DNA Colonocytes Screening 

Notes

Acknowledgment

This work was supported by Diatech Pharmacogenetics, Jesi (AN)—Italy.

References

  1. 1.
    Fearon ER, Vogelstein B (1990) A genetic model for colorectal tumorigenesis. Cell 61(5):759–767CrossRefPubMedGoogle Scholar
  2. 2.
    Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray, F. GLOBOCAN 2012 v1.0, Cancer incidence and mortality worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer; 2013. Available from: http://globocan.iarc.fr. Accessed 10 Nov 2016.
  3. 3.
    Levin B, Lieberman DA, McFarland B et al (2008) Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology 134:1570–1595.  https://doi.org/10.1053/j.gastro.2008.02.002CrossRefPubMedGoogle Scholar
  4. 4.
    Quintero E, Castells A, Bujanda L et al (2012) Colonoscopy versus fecal immunochemical testing in colorectal-cancer screening. N Engl J Med 366:697–706.  https://doi.org/10.1056/NEJMoa1108895CrossRefPubMedGoogle Scholar
  5. 5.
    Bosch LJ, Carvalho B, Fijneman RJ et al (2011) Molecular tests for colorectal cancer screening. Clin Colorectal Cancer 10:8–23.  https://doi.org/10.3816/CCC.2011.n.002CrossRefPubMedGoogle Scholar
  6. 6.
    Ahlquist DA (2010) Molecular detection of colorectal neoplasia. Gastroenterology 138:2127–2139.  https://doi.org/10.1053/j.gastro.2010.01.055CrossRefPubMedGoogle Scholar
  7. 7.
    Ahlquist DA, Harrington JJ, Burgart LJ et al (2000) Morphometric analysis of the “mucocellular layer” overlying colorectal cancer and normal mucosa: relevance to exfoliation and stool screening. Hum Pathol 31:51–57CrossRefPubMedGoogle Scholar
  8. 8.
    De Maio G, Rengucci C, Zoli W et al (2014) Circulating and stool nucleic acid analysis for colorectal cancer diagnosis. World J Gastroenterol 20:957–967.  https://doi.org/10.3748/wjg.v20.i4.957CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Rengucci C, De Maio G, Menghi M et al (2014) Improved stool DNA integrity method for early colorectal cancer diagnosis. Cancer Epidemiol Biomarkers Prev 23:2553–2560.  https://doi.org/10.1158/1055-9965.EPI-14-0379CrossRefPubMedGoogle Scholar
  10. 10.
    Calistri D, Rengucci C, Bocchini R et al (2003) Fecal multiple molecular tests to detect colorectal cancer in stool. Clin Gastroenterol Hepatol 1:377–383.  https://doi.org/10.1053/S1542-3565(03)00186-1CrossRefPubMedGoogle Scholar
  11. 11.
    Calistri D, Rengucci C, Lattuneddu A et al (2004) Detection of colorectal cancer by a quantitative fluorescence determination of DNA amplification in stool. Neoplasia 6:536–540.  https://doi.org/10.1593/neo.04190CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Calistri D, Rengucci C, Molinari C et al (2009) Quantitative fluorescence determination of long-fragment DNA in stool as a marker for the early detection of colorectal cancer. Cell Oncol 31:11–17.  https://doi.org/10.3233/CLO-2009-0443PubMedGoogle Scholar
  13. 13.
    Calistri D, Rengucci C, Casadei Gardini A et al (2010) Fecal DNA for noninvasive diagnosis of colorectal cancer in immunochemical fecal occult blood test-positive individuals. Cancer Epidemiol Biomarkers Prev 19:2647–2654.  https://doi.org/10.1158/1055-9965.EPI-10-0291CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  • Claudia Rengucci
    • 1
  • Giulia De Maio
    • 1
  • Maura Menghi
    • 2
  • Daniele Calistri
    • 1
  1. 1.Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCSMeldolaItaly
  2. 2.Diatech PharmacogeneticsJesiItaly

Personalised recommendations